Lasix and Nephrogenic systemic fibrosis - a phase IV clinical study of FDA data
Nephrogenic systemic fibrosis is found among people who take Lasix, especially for people who are male, 60+ old, have been taking the drug for < 1 month.
The phase IV clinical study analyzes which people take Lasix and have Nephrogenic systemic fibrosis. It is created by eHealthMe based on reports of 196,293 people who have side effects when taking Lasix from the FDA, and is updated regularly. You can use the study as a second opinion to make health care decisions.
Phase IV trials are used to detect adverse drug outcomes and monitor drug effectiveness in the real world. With medical big data and AI algorithms, eHealthMe is running millions of phase IV trials and makes the results available to the public. Our original studies have been referenced on 600+ medical publications including The Lancet, Mayo Clinic Proceedings, and Nature.
196,293 people reported to have side effects when taking Lasix.
Among them, 436 people (0.22%) have Nephrogenic systemic fibrosis.
What is Lasix?
Lasix has active ingredients of furosemide. It is often used in swelling. eHealthMe is studying from 190,798 Lasix users for its effectiveness, alternative drugs and more.
What is Nephrogenic systemic fibrosis?
Nephrogenic systemic fibrosis (involves fibrosis of skin, joints, eyes due to kidney disease) is found to be associated with 915 drugs and 621 conditions by eHealthMe.
Number of Lasix and Nephrogenic systemic fibrosis reports submitted per year:
Time on Lasix when people have Nephrogenic systemic fibrosis *:
Gender of people who have Nephrogenic systemic fibrosis when taking Lasix*:
Age of people who have Nephrogenic systemic fibrosis when taking Lasix *:
Common drugs people take besides Lasix *:
Common side effects people have besides Nephrogenic systemic fibrosis *:
Common conditions people have *:
* Approximation only. Some reports may have incomplete information.
Do you take Lasix and have Nephrogenic systemic fibrosis?Check whether Nephrogenic systemic fibrosis is associated with a drug or a condition
How to use the study?
You can discuss the study with your doctor, to ensure that all drug risks and benefits are fully discussed and understood.
Related publications that referenced our studies
- Ochoa PS, Fisher T, "A 7‐Year Case of Furosemide‐Induced Immune Thrombocytopenia", Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy, 2013 Jul .
How severe was Nephrogenic systemic fibrosis and when was it recovered:
Expand to all the drugs that have ingredients of furosemide:
Alternative drugs to, pros and cons of Lasix:
- Lasix (190,798 reports)
Common Lasix side effects:
Browse all side effects of Lasix:a b c d e f g h i j k l m n o p q r s t u v w x y z
Nephrogenic systemic fibrosis treatments and more:
- Nephrogenic systemic fibrosis (6,156 reports)
COVID vaccines that are related to Nephrogenic systemic fibrosis:
- Nephrogenic systemic fibrosis in Moderna COVID Vaccine
- Nephrogenic systemic fibrosis in Pfizer BioNTech Covid Vaccine
- Nephrogenic systemic fibrosis in Johnson and Johnson Covid Vaccine
Common drugs associated with Nephrogenic systemic fibrosis:
All the drugs that are associated with Nephrogenic systemic fibrosis:
- Nephrogenic systemic fibrosis (915 drugs)
Common conditions associated with Nephrogenic systemic fibrosis:
All the conditions that are associated with Nephrogenic systemic fibrosis:
- Nephrogenic systemic fibrosis (621 conditions)
How the study uses the data?
The study uses data from the FDA. It is based on furosemide (the active ingredients of Lasix) and Lasix (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.
Who is eHealthMe?
With medical big data and proven AI algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 600+ medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).
WARNING, DISCLAIMER, USE FOR PUBLICATION
WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.
DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.
If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.
Recent studies on eHealthMe:
- Ambien and Gastritis Atrophic - 2 seconds ago
- Lescol Xl and Blood Creatine Phosphokinase Mb - 4 seconds ago
- Lasix and Nephrogenic Systemic Fibrosis - 4 seconds ago
- Minirin and Nosebleed - 5 seconds ago
- Akynzeo and Atherosclerosis - 10 seconds ago
- Transderm Scop and Intervertebral Disc Protrusion - 13 seconds ago
- Zepatier and Ampyra drug interaction - 14 seconds ago
- Lasix and Lumbar Vertebral Fracture - 23 seconds ago
- Keppra and Lipoic Acid drug interaction - 28 seconds ago
- Tofacitinib Citrate and Infusion Related Reaction - 28 seconds ago